Tim E. Hawkins
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 9
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Stephen E. Moss (5 shared papers)John M. Burke (9 shared papers)David Simpson (9 shared papers)Ian W. Flinn (9 shared papers)Peter Wood (9 shared papers)David MacDonald (9 shared papers)Kathryn S. Kolibaba (9 shared papers)Samar Issa (9 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Blood (4 papers)Cell Biochemistry and Biophysics (1 paper)Current Biology (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (1 paper)
- Partner nations
- United StatesAustraliaNew Zealand
In The Last Decade
Tim E. Hawkins
15 papers receiving 866 citations
Hit Papers
Peers
Comparison fields: 5 of 62
- Pathology and Forensic Medicine 614
- Genetics 320
- Oncology 497
- Neurology 137
- Reproductive Medicine 61
Countries citing papers authored by Tim E. Hawkins
This map shows the geographic impact of Tim E. Hawkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim E. Hawkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim E. Hawkins more than expected).
Fields of papers citing papers by Tim E. Hawkins
This network shows the impact of papers produced by Tim E. Hawkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim E. Hawkins. The network helps show where Tim E. Hawkins may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim E. Hawkins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study Hit paper breakdown → | 2014 | 419 |
| 2 | 2019 | 166 | |
| 3 | 1999 | 61 | |
| 4 | 2000 | 50 | |
| 5 | 1999 | 47 | |
| 6 | 2002 | 46 | |
| 7 | 2012 | 26 | |
| 8 | 1998 | 17 | |
| 9 | 2016 | 14 | |
| 10 | 2017 | 13 | |
| 11 | 2017 | 10 | |
| 12 | 2012 | 5 | |
| 13 | 2000 | 3 | |
| 14 | 2013 | 3 | |
| 15 | 2013 | 2 |
About Tim E. Hawkins
Tim E. Hawkins is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Genetics, having authored 15 papers that have together received 882 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), S100 Proteins and Annexins (4 papers), Colorectal Cancer Treatments and Studies (3 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), Ion channel regulation and function (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (614 citations), Genetics (320 citations), Oncology (497 citations), Neurology (137 citations) and Reproductive Medicine (61 citations). Tim E. Hawkins has collaborated with scholars based in United States, Australia and New Zealand. Frequent co-authors include Stephen E. Moss, John M. Burke, David Simpson, Ian W. Flinn, Peter Wood, David MacDonald, Kathryn S. Kolibaba, Samar Issa, Brad S. Kahl and Doreen M. Hallman. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cell Biochemistry and Biophysics, Current Biology and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.